tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
J&J confirms FDA approves quadruplet regimen for multiple myeloma
PremiumThe FlyJ&J confirms FDA approves quadruplet regimen for multiple myeloma
9d ago
FDA approves Darzalex Faspro combo for newly diagnosed multiple myeloma
Premium
The Fly
FDA approves Darzalex Faspro combo for newly diagnosed multiple myeloma
9d ago
Johnson & Johnson call volume above normal and directionally bullish
Premium
The Fly
Johnson & Johnson call volume above normal and directionally bullish
9d ago
Johnson & Johnson price target raised to $220 from $205 at Stifel
PremiumThe FlyJohnson & Johnson price target raised to $220 from $205 at Stifel
14d ago
Johnson & Johnson price target raised to $250 from $240 at Goldman Sachs
Premium
The Fly
Johnson & Johnson price target raised to $250 from $240 at Goldman Sachs
14d ago
Johnson & Johnson price target raised to $221 from $220 at BofA
Premium
The Fly
Johnson & Johnson price target raised to $221 from $220 at BofA
14d ago
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
PremiumThe FlyMidday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
15d ago
Johnson & Johnson says ‘very confident’ in 2026 outlook
Premium
The Fly
Johnson & Johnson says ‘very confident’ in 2026 outlook
15d ago
Johnson & Johnson says entering 2026 with ‘powerful momentum’
Premium
The Fly
Johnson & Johnson says entering 2026 with ‘powerful momentum’
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100